Key Takeaways ISRG grows via da Vinci 5, Ion platform, and 85% recurring revenues. ZBH ROSA robotics, cementless knees, and ASC push fuel steady growth. ISRG trades rich vs peers (Value Score D), ZBH looks cheaper (Value Score A). The robotic surgery market is undergoing rapid transformation, driven by technological advancements, increasing adoption in hospitals, and a shift toward minimally invasive procedures. As of 2025, it’s growing rapidly, focusing on precision, AI integration, and expanding its use a ...